Top Markets
#1 BOOK OF MEME BOOK OF MEME +21.45%
#2 SSV Network SSV Network +21.25%
#3 XPIN Network XPIN Network +20.61%
#4 Bitcoin Cash Bitcoin Cash +16.21%
#5 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +16.15%
#6 The Black Bull The Black Bull +16.05%
#7 Geodnet Geodnet +15.77%
#8 Mubarak Mubarak +15.70%
#9 Derive Derive +15.55%
#10 Neiro Neiro +14.61%
Coin of the day
BOOK OF MEME BOOK OF MEME
設定
言語
日本
通貨
USD
テーマ
Cortexyme, Inc. Cortexyme, Inc.

Cortexyme, Inc.

CRTX
株式のランク #25183
Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to... Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to pioneering new therapies for Alzheimer's and various other degenerative conditions. The company's primary investigational drug, atuzaginstat (also known as COR388), is an orally delivered, small molecule inhibitor engineered to cross the blood-brain barrier and target gingipain. This compound is currently in Phase II/III clinical trials, where it is being assessed for its potential use in individuals with mild to moderate Alzheimer's disease, as well as for tackling oral squamous cell carcinoma, periodontitis, and coronavirus infections. Established in 2012, Cortexyme, Inc. is headquartered in South San Francisco, California.
株価
$1.95
最終同期: 2022-07-29
時価総額
$52.48M
変化（1日）
2.63%
変化（1年）
0.00%
国
US
取引 Cortexyme, Inc. (CRTX)

カテゴリー

Healthcare
Cortexyme, Inc.（CRTX）の配当利回りの履歴
Cortexyme, Inc.（銘柄コード: CRTX）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Cortexyme, Inc.（CRTX）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US